RadNet Announces the Agenda for its November 11, 2025 Investor Day

Rhea-AI Summary

RadNet (NASDAQ: RDNT) announced its Investor Day agenda for Tuesday, November 11, 2025, to be held 9:00 a.m.–2:30 p.m. ET at Nasdaq MarketSite in New York City with a live webcast and archived replay available.

Titled “On the Leading Edge of Healthcare: Advancing Imaging Through Innovation and Technology,” the event includes opening remarks and a financial overview, clinical spotlights, digital health and services presentations, demonstrations of DeepHealth AI products (Breast Suite, Diagnostic Suite, TechLive™, Patient Engagement), and two Q&A sessions. In-person attendance is by invitation; investors may request consideration via rdnt@addo.com.

News Market Reaction – RDNT

+0.86%

1 alert

+0.86% News Effect

On the day this news was published, RDNT gained 0.86%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and a premier global developer of digital health solutions, is pleased to unveil the agenda for the company’s Investor Day.

The event will take place on Tuesday, November 11, 2025 from 9:00 a.m. to 2:30 p.m. Eastern Standard Time at the Nasdaq MarketSite in New York City. In-person attendance is by invitation only and investors can request such consideration by emailing rdnt@addo.com. Those unable to participate onsite can view a live webcast at https://edge.media-server.com/mmc/p/rz6bqgzd/ or see an archived replay of the event in the Investor Relations section of RadNet’s website.

Titled “On the Leading Edge of Healthcare: Advancing Imaging Through Innovation and Technology,” the Investor Day will feature presentations from select RadNet senior executives and clinical leaders who will share the company’s current and longer-term strategic priorities, market opportunities and innovation roadmap.

The agenda is as follows:

• 9:00 to 9:20 a.m. – Opening Remarks and Financial Overview
• 9:20 to 11:00 a.m. – Expert Clinical Spotlights and Services Division Presentation
• 11:00 to 11:30 a.m. – Q&A Session
• 12:15 to 1:15 p.m. – Digital Health Division Presentation
• 1:15 to 1:45 p.m. – Discussion About Unique Synergy of Services and Digital Health
• 1:45 to 1:55 p.m. – Value-Creation Plan Towards 2028
• 2:00 to 2:30 p.m. – Q&A Session
  

In-person attendees will have the exclusive opportunity to engage with RadNet’s leadership, talk with clinical and research experts and view the following demonstrations of RadNet’s DeepHealth cloud-native AI products:

• Breast Suite – A portfolio of solutions designed to enhance quality, workflows and other aspects of diagnosing breast cancer.
• Diagnostic Suite – Imaging platform that unites picture archiving and communications systems (PACS), multi-modality viewing, automated reporting, workflow tools and various AI-empowered clinical processes.
• TechLive™ – Vendor-agnostic, remote scanning and radiology management solution designed to extend expert support for MR, ultrasound, CT and PET/CT across large, multi-site operations.
• Patient Engagement – A portfolio of solutions aimed at improving patient scheduling, onboarding, follow-up interactions and online payments.

About RadNet, Inc.
RadNet, Inc. is a leading provider of outpatient diagnostic imaging services in the United States, with a network of 405 owned and/or operated imaging centers. The company’s markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members. For more information, visit www.radnet.com.

Contact:
RadNet, Inc.
Mark Stolper
Executive Vice President and Chief Financial Officer
310-445-2928

Or

Jane Mazur
Senior Vice President, Corporate Communications
Jane.Mazur@RADNET.COM

Investor Relations:
Addo IR
rdnt@addo.com

FAQ

When and where is RadNet's Investor Day on November 11, 2025 (RDNT)?

RadNet's Investor Day is on Tuesday, November 11, 2025, 9:00 a.m.–2:30 p.m. ET at Nasdaq MarketSite in New York City with a live webcast available.

How can investors watch the RadNet (RDNT) Investor Day webcast or access a replay?

Investors can view the live webcast at https://edge.media-server.com/mmc/p/rz6bqgzd/ and access an archived replay in RadNet's Investor Relations website.

What is on the RadNet (RDNT) Investor Day agenda for November 11, 2025?

Agenda items include an opening financial overview, clinical spotlights, digital health and services presentations, demonstrations of DeepHealth AI products, a value-creation plan toward 2028, and two Q&A sessions.

How can investors request in-person attendance at RadNet's November 11, 2025 Investor Day?

In-person attendance is by invitation; investors may request consideration by emailing rdnt@addo.com.

Which RadNet DeepHealth AI products will be demonstrated at the November 11, 2025 Investor Day?

Demonstrations will include Breast Suite, Diagnostic Suite, TechLive™, and Patient Engagement solutions.

Will RadNet (RDNT) discuss strategic priorities and long-term plans at Investor Day?

Yes; senior executives and clinical leaders will present current and longer-term strategic priorities, market opportunities, and an innovation roadmap including a value-creation plan toward 2028.